Photoactivatable neuropeptides for spatiotemporally precise delivery of opioids in neural tissue.

Department of Neurobiology, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA.
Neuron (Impact Factor: 15.98). 01/2012; 73(2):249-59. DOI: 10.1016/j.neuron.2011.11.016
Source: PubMed

ABSTRACT Neuropeptides activate G protein-coupled receptors to acutely modulate cellular excitability and synaptic transmission. However, due to the lack of reagents for precise delivery of peptides within dense brain tissue, the spatiotemporal scale over which neuropeptides act is unknown. To achieve rapid and spatially delimited delivery of neuropeptides in mammalian brain tissue, we developed photoactivatable analogs of two opioids: [Leu⁵]-enkephalin (LE) and the 8 amino acid form of Dynorphin A (Dyn-8). These peptides are functionally inactive prior to photolysis, and exposure to ultraviolet (UV) light causes clean release of LE and Dyn-8. Recordings from acute slices of rat locus coeruleus (LC) demonstrated that photorelease of LE activates mu opioid receptor-coupled K+ channels with kinetics that approach the limits imposed by G protein-mediated signaling. Temporally precise and spatially delimited photorelease revealed the kinetics and ionic nature of the mu opioid response and the mechanisms that determine the spatial profile of enkephalinergic volume transmission in LC.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper is the thirty-fifth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2012 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17).
    Peptides 10/2013; 50. DOI:10.1016/j.peptides.2013.10.001 · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Desensitization of μ-opioid receptors (MORs) develops over 5-15 min following application of some but not all opioid agonists and lasts for 10s of min following agonist removal. The decrease in function is receptor selective (homologous) and could result from (1) a reduction in receptor number or (2) a decrease in receptor coupling. The present investigation used photolysis of two caged opioid ligands in order to examine the kinetics of MOR-induced potassium conductance before and following MOR desensitization. Photolysis of a caged antagonist, caged-naloxone (CNV-NLX), blocked the current induced by a series of agonists and the time constant of decline was significantly decreased following desensitization. The increase in the rate of current decay was not observed following partial blockade of receptors with the irreversible antagonist, β-CNA. The time constant of current decay following desensitization was never more rapid than 1s, suggesting an increased agonist off rate rather than an increase in the rate of channel closure downstream of the receptor. The rate of GIRK current activation was examined using photolysis of a caged agonist, [Leu](5)enkephalin (CYLE). Following acute desensitization or partial irreversible block of MORs with β-CNA there was an increase in the time it took to reach a peak current. The decrease in the rate of agonist-induced GIRK conductance was receptor selective and dependent on receptor number. The results indicate that opioid receptor desensitization reduced the number of functional receptors and the remaining active receptors have a reduced agonist affinity.
    Molecular pharmacology 04/2014; 86(1). DOI:10.1124/mol.114.092098 · 4.12 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Opioid receptors (ORs) are widely distributed in the brain, the spinal cord, and the digestive tract and play an important role in nociception. All known ORs are G-protein-coupled receptors (GPCRs) of family A. Another well-known member of this family, rhodopsin, is activated by light through the cis/trans isomerization of a covalently bound chromophore, retinal. We now show how an OR can be combined with a synthetic azobenzene photoswitch to gain light sensitivity. Our work extends the reach of photopharmacology and outlines a general strategy for converting Family A GPCRs, which account for the majority of drug targets, into photoreceptors.
    Angewandte Chemie International Edition 03/2014; 53(12). DOI:10.1002/anie.201309633 · 11.34 Impact Factor

Full-text (2 Sources)

Available from
May 23, 2014